NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105.
Quarter-by-quarter ownership
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RHO CAPITAL PARTNERS INC | 3,766,666 | $66,708,000 | 43.30% |
Ponoi II Management, LLC | 1,298,908 | $23,004,000 | 41.78% |
Column Group LLC | 15,396,116 | $272,665,000 | 37.08% |
Ponoi Management, LLC | 1,298,908 | $23,004,000 | 21.21% |
Euclidean Capital LLC | 746,674 | $13,224,000 | 7.52% |
StepStone Group LP | 1,573,357 | $27,864,000 | 1.59% |
Logos Global Management LP | 475,000 | $8,412,000 | 0.87% |
First Light Asset Management, LLC | 570,898 | $10,111,000 | 0.72% |
BVF INC/IL | 955,000 | $16,913,000 | 0.61% |
DAFNA Capital Management LLC | 80,485 | $1,425,000 | 0.36% |